PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2004

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/06/2004
Quarter2
Financial Year End31/12/2004
The figureshave not been audited

Attachments

pharma_klse0406_final.doc
287 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2004


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2004 
30/06/2003 
30/06/2004 
30/06/2003 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
178,644
155,262
369,949
309,787
2Profit/(loss) before tax
16,264
13,347
36,933
31,260
3Profit/(loss)
after tax and minority
interest
10,882
8,389
23,266
20,035
4Net profit/(loss) for
the period
10,882
8,389
23,266
20,035
5Basic earnings/(loss) per share (sen)
10.77
8.39
23.05
20.03
6Dividend per share (sen)
4.50
3.50
4.50
3.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

2.3800
2.2200

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Board of Directors of Pharmaniaga Berhad recommends an interim tax exempt dividend of 4.5 sen per share (2003: tax exempt dividend of 3.5 sen per share). The dates of entitlement and payment will be announced at a later date.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced6 Aug 2004  
CategoryFinancial Results
Reference NoCC-040803-62728